相关实验视频

Updated: May 17, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

揭示了EGCG的抗癌潜力:通过"体外"检测,触发肺癌细胞系中的细胞亡

Al Moutassem Billah Khair^1,2, Alexander Maniangat Luke^1,2, Rajashree Patnaik¹

¹Department of Basic Medical & Dental Sciences, College of Dentistry, Ajman University, Ajman, United Arab Emirates.

|March 31, 2025

概括

绿茶中的表甲基-3-酸盐 (EGCG) 通过降低PI3K/Akt通路的调节,诱导细胞亡并抑制肺癌细胞的生长. 这项研究突出了EGCG的EGCG.

科学领域:

生物化学生物化学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

肺癌仍然是一个重大的全球健康挑战,需要新的治疗策略.
绿茶中的一种成分 - - 甲基-3-酸盐 (EGCG) 具有潜在的抗癌特性.
了解EGCG对抗肺癌的机制对于治疗开发至关重要.

研究的目的:

研究EGCG对酸-3-酶/蛋白酶B (PI3K/Akt) 信号通路的影响.
确定EGCG在诱导H1299和A549肺癌细胞中亡中的作用.
阐明EGCG抗癌活性背后的分子机制.

主要方法:

暴露H1299和A549肺癌细胞系72小时的不同EGCG度.
评估细胞反应,包括细胞亡,增殖和迁移.
对蛋白质表达水平的分析,重点关注PI3K/Akt路径组件.

主要成果:

EGCG证明了对肺癌细胞增殖和迁移的剂量依赖抑制.
在H1299和A549细胞中,EGCG显著增加了亡率.
EGCG的使用导致化Akt (p-Akt) 和PI3K (p-PI3K) 水平显著降低,这表明该途径受阻.

结论:

EGCG有效地抑制了肺癌细胞中PI3K/Akt信号通路的激活.
EGCG促进了亡,抑制了增殖/迁移,支持了它的治疗潜力.
这些发现强调了EGCG作为肺癌治疗的天然剂的承诺.

关键词:

A549 细胞 A549 细胞细胞亡的速度是多少细胞的增殖细胞的增殖.甲基甲基素-3-酸盐 (EGCG) 是一种 H1299 细胞的细胞肺癌是一种肺癌.蛋白质表达方式蛋白质表达方式

更多相关视频

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration

Published on: March 17, 2018

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...